arrow
G

Gerassimos J. Mantzaris

chu de nancy
H指数:51
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Predictors of Response to Induction Therapy with Ustekinumab in Patients with Ulcerative Colitis: Results from a National Study in Greece

希腊国家研究中溃疡性结肠炎患者对乌司奴单抗诱导治疗的应答预测因子:结果

2026-04-190
OA
Crypt-Level Tight Junction Remodeling Is Associated with Disease Course and Clinical Outcomes in Inflammatory Bowel Disease

隐窝水平紧密连接重塑与炎症性肠病病程及临床结局相关

Cells
IF5.2
2026-04-150
OA
Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease

立场文件:IOlBD 基于证据的共识——人工智能在炎症性肠病临床试验中内镜和组织学终点评估中的应用

2026-03-090
PRE
Value of tofacitinib extended induction therapy in patients with moderate-to-severe ulcerative colitis: A real-world 52-week follow-up study

托法替布延长诱导治疗在中重度溃疡性结肠炎患者中的价值:一项真实世界52周随访研究

2025-11-140
PRE
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class

溃疡性结肠炎中JAK抑制剂的序贯治疗:同类别转换治疗的有效性与安全性

2025-11-030
PRE
International Survey of Gastroenterologists on Managing Inflammatory Bowel Disease During Pregnancy and Lactation: Current State and the Necessity for Improvements

关于妊娠和哺乳期炎症性肠病管理的国际胃肠病学家调查:现状与改进的必要性

2025-10-140
OAAI
Establishing a multiple outcome set for Crohn's disease in real-world evidence studies: results from a Delphi e-survey

为克罗恩病真实世界证据研究建立多结局集:德尔菲电子调查的结果

2025-10-010
PRE
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study
2024-07-092
OA
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
2024-02-283
OAAI
Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial

姜黄素-青黛联合治疗活动性溃疡性结肠炎: 一项随机、双盲、安慰剂对照试验

2024-02-0118
PRE
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus Conference
2023-12-192
PRE
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
2023-09-0130
PRE
The Inflammatory Bowel Disease-Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version
2023-04-213
OAAI